Amanote Research
Register
Sign In
MITF Upregulation Sensitizes Melanoma Cells to Antifolate Treatment
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2013-143
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
July 3, 2013
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells
Clinical Cancer Research
Cancer Research
Oncology
1200 SIRT7 Epigenetically Regulates MITF to Promote Melanoma Growth
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Kanglaite Sensitizes Colorectal Cancer Cells to Taxol via NF-κΒ Inhibition and Connexin 43 Upregulation
Scientific Reports
Multidisciplinary
Pro-Survival Role of MITF in Melanoma
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Ribozyme-Mediated Attenuation of Survivin Expression Sensitizes Human Melanoma Cells to Cisplatin-Induced Apoptosis
Journal of Clinical Investigation
Medicine
MITF Expression Predicts Therapeutic Vulnerability to P300 Inhibition in Human Melanoma
Cancer Research
Cancer Research
Oncology
McL-1, BCL-XL and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in Microenvironment
PLoS ONE
Multidisciplinary
791 Up-Regulated SIRT7 Expression Contributed to Melanoma Growth by Promoting MITF Expression
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Interactions of Melanoma Cells With Distal Keratinocytes Trigger Metastasis via Notch Signaling Inhibition of MITF
Molecular Cell
Cell Biology
Molecular Biology